Targeted treatment produces rapid shrinkage of recurrent, BRAF-mutant brain tumor
A team led by Massachusetts General Hospital (MGH) investigators has reported the first successful use of a targeted therapy drug to treat a patient with a debilitating, recurrent brain tumor. In a paper published online ...
Nov 6, 2015